Loading...
Digoxin — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Digoxin
2025-Q4
Comprehensive analysis of India’s digoxin export trade — suppliers, buyers, prices, routes, and every shipment record.
77
Shipments
$194K
Trade Value
48
Suppliers
33
Buyers
38
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/digoxin
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s digoxin trade — 2025-Q4
KEY TAKEAWAY
Digoxin 2025-Q4 exports total $193.8K across 38 countries, with ACME GENERICS PVT LTD commanding 34.3% market share.
TOTAL SHIPMENTS
77
2025-Q4
EXPORT VALUE
$193.8K
FOB USD
TOTAL QUANTITY
1.8M
units shipped
INDIAN SUPPLIERS
48
unique exporters
GLOBAL BUYERS
33
unique importers
DESTINATIONS
38
countries
MEDIAN UNIT PRICE
$0.186
per unit
TOP-5 SHARE
73.1%
of total USD
BRANDED SHARE
61.0%
47 shipments
DOSAGE FORMS
4
product types
6 KEY FINDINGS
1
ACME GENERICS PVT LTD is India's #1 Digoxin exporter with $66.5K (34.3% market share).→ §5, Indian Supplier Rankings
2
Digoxin reached 38 countries, with Canada as the top destination ($66.5K).→ §4, Global Destination Map
3
Market concentration is moderate (HHI: 1665) — top 10 suppliers control 90.2% of exports.→ §5, Indian Supplier Rankings
4
93.9% of buyers (31 of 33) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (77.7%) across 4 dosage forms.→ §7, Price Benchmarks
6
38 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 ACME GENERICS PVT LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian digoxin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Digoxin report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial digoxin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian digoxin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Digoxin India trade report
Product scope
Digoxin
All variants merged — branded and generic formulations of digoxin
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
77
Every commercial digoxin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a v-curve: Oct $55.5K, Nov $15.1K, Dec $123.2K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$55.5K
Oct USD
16 shipments
2
$15.1K
Nov USD
-72.8% MoM
3
$123.2K
Dec USD
+717.1% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 72.8% in USD but shipment count kept steady.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $56K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $194K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $40K dip in Nov, $108K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $56K | 16 shipments |
| Nov | $15K | 12 shipments |
| Dec | $123K | 49 shipments |
| Q4 Total | $194K | 77 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Myanmar held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: GOD GIFT LABORATORY PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import digoxin from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Canada absorbs 34.3% of India’s 2025-Q4 digoxin trade ($66.5K). Beyond the top 10 destinations, 38 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 15 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 38 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much digoxin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$73K
37.6% of trade
11 countries · 21 shipments
Europe
$5
0.0% of trade
2 countries · 3 shipments
Americas
$93K
47.8% of trade
7 countries · 17 shipments
Africa
$28K
14.6% of trade
15 countries · 32 shipments
Oceania
$102
0.1% of trade
3 countries · 4 shipments
Fig 4.1 Canada is the #1 corridor ($66K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian digoxin it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Canada | $66K | 2 | ACME GENERICS PVT LTD | $66K | — | — | — | — |
| 2 | Georgia | $26K | 1 | VELLINTON HEALTHCARE | $26K | — | — | — | — |
| 3 | Sri Lanka | $20K | 1 | UNICURE REMEDIES PVT LTD | $20K | — | — | — | — |
| 4 | Myanmar | $19K | 2 | SWIPHA EXPORTS PVT LTD | $19K | — | — | — | — |
| 5 | Venezuela | $17K | 3 | S.D.PHARMACEUTICALS | $9K | RONALD PHARMACEUTICALS PVT LTD | $8K | — | — |
| 6 | Nigeria | $10K | 2 | MANCARE PHARMACEUTICALS PVT LTD | $10K | — | — | — | — |
| 7 | Mozambique | $8K | 5 | NARANG MEDICAL LTD | $5K | ALLOTAB HEALTHCARE LLP | $4K | — | — |
| 8 | Algeria | $5K | 1 | SWISS PARENTERALS LTD | $5K | — | — | — | — |
| 9 | Dominican Republic | $5K | 1 | MEDICO REMEDIES LTD | $5K | — | — | — | — |
| 10 | Guyana | $4K | 5 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD | $4K | H V A INTERNATIONAL | $279 | PEAK HEALTHCARE | $6 |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 37.6% of USD — but Canada is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
34.3%
#1 country share
Canada alone
77.0%
Top 5 share
5 of 38 countries
98.9%
Top 15 share
Long tail of 23 countries = 1.1%
HHI 1712
Destination HHI
Moderately concentrated
38
Countries served
Global pharma reach from India
15
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
48 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
ACME GENERICS PVT LTD ($66.5K, 34.3% share) and VELLINTON HEALTHCARE ($26.1K) together control 47.8% of India’s 2025-Q4 digoxin trade. The top 5 suppliers hold 73.1%. 48 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian digoxin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 ACME GENERICS PVT LTD leads by $40K over VELLINTON HEALTHCARE — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: GOD GIFT LABORATORY is #14 by value but #2 by volume.
Fig 5.2 ALLOTAB HEALTHCARE LLP also leads by shipment count (4) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: GOD GIFT LABORATORY moves from #2 by volume to #14 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 48 digoxin suppliers split into strategic segments
KEY TAKEAWAY
12 suppliers (25%) generate 93.9% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 ACME GENERICS PVT LTD and VELLINTON HEALTHCARE sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 93.9% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | ACME GENERICS PVT LTD | 1 | 1 | $66K |
| 2 | VELLINTON HEALTHCARE | 1 | 1 | $26K |
| 3 | UNICURE REMEDIES PVT LTD | 1 | 1 | $20K |
| 4 | SWIPHA EXPORTS PVT LTD | 1 | 1 | $19K |
| 5 | MANCARE PHARMACEUTICALS PVT LTD | 1 | 1 | $10K |
| 6 | S.D.PHARMACEUTICALS | 1 | 1 | $9K |
| 7 | RONALD PHARMACEUTICALS PVT LTD | 1 | 1 | $8K |
| 8 | SWISS PARENTERALS LTD | 1 | 2 | $6K |
| 9 | MEDICO REMEDIES LTD | 1 | 1 | $5K |
| 10 | NARANG MEDICAL LTD | 1 | 1 | $5K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the digoxin manufacturing hubs
KEY TAKEAWAY
Nalagarh and Vadodara together account for $95K of India’s 2025-Q4 digoxin trade.
Fig 5.5 Nalagarh (1 exporters, $66K) and Vadodara (4 exporters, $29K) are India’s digoxin capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
73.1%
Top 5 share
5 of 48 suppliers
90.2%
Top 10 share
10 of 48 suppliers
93.9%
Top 25% share
12 suppliers = 94% USD
HHI 1665
Supplier HHI
Moderate
48
Total suppliers
shipped Digoxin in 2025-Q4
20+ cities
Indian hubs
Nalagarh and Vadodara lead
§5.2 Coming next: 0 exporter deep-dive profiles
Each of the top 0 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
33 importers across 38 countries — who is buying Indian digoxin and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 75.5% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian digoxin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 JAMP PHARMA CORP is the #1 importer at $66K (34.3%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
94%
Single-source
31 buyers rely on exactly 1 Indian supplier
3%
Dual-source
1 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
3%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source digoxin from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Seychelles 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SEYCHELLES HOSPITAL | SAMARTH LIFE SCIENCE… | $393.884 | $2.626 | Tablet |
| MINISTRY OF HEALTH | HLL LIFECARE LTD | $39.932 | $0.0010 | Tablet |
| GOOD HEALTH (PTY) LTD | AL-SUPREME EXPORTS | $0.162 | $0.0016 | Tablet |
Sudan 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| QUEEENS ENTERPRISES CO… | BAKER & DAVIS PVT LTD | $29.947 | $0.060 | Tablet |
| MADAU KUAAC AYAI KON | AFRO LIFESCIENCE | $3.204 | $0.032 | Tablet |
Afghanistan 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MUBARAK HASHIMI LTD | KERK | $29.618 | $0.123 | Tablet |
| GULF IMPEX FZC | MEDMATRIX ASSOCIATES | $4.924 | $0.0098 | Tablet |
Canada 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| JAMP PHARMA CORP | ACME GENERICS PVT LTD | $66K | $1.667 | Tablet |
Georgia 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MINISTRY OF HEALTH AND… | VELLINTON HEALTHCARE | $26K | $2.609 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | JAMP PHARMA CORP | Canada | $66K | $33K | Mid |
| 2 | MINISTRY OF HEALTH A… | Georgia | $26K | $26K | Mid |
| 3 | BANK OF CEYLON | Sri Lanka | $20K | $20K | Mid |
| 4 | MANFES PHARMACEUTICA… | Nigeria | $10K | $5K | Budget |
| 5 | VISION DROMEFAR, C.A | Venezuela | $9K | $5K | Budget |
| 6 | SAAD MEDICAL | Dominican Republic | $5K | $5K | Budget |
| 7 | KARMA PHARMACEUTICAL… | Bhutan | $3K | $2K | Budget |
| 8 | DERDE DERMAN | Turkmenistan | $2K | $826.000 | Budget |
| 9 | LUSAKA PHARMACEUTICA… | Zambia | $2K | $2K | Budget |
| 10 | SALAMA(CENTRAL PURCH… | Madagascar | $547.250 | $547.000 | Budget |
| 11 | TOTHE ORDER SHARJAH … | Angola | $445.008 | $223.000 | Budget |
| 12 | SEYCHELLES HOSPITAL | Seychelles | $393.884 | $394.000 | Budget |
| 13 | NEW GPC INC | Guyana | $279.456 | $279.000 | Budget |
| 14 | AL MAAYER ALASRYAH C… | Saudi Arabia | $220.439 | $220.000 | Budget |
| 15 | ALLIANCE PHARMA SARL | Guinea-Bissau | $118.555 | $119.000 | Budget |
| 16 | TO,THE ORDER OF | Fiji | $80.686 | $81.000 | Budget |
| 17 | MINISTRY OF HEALTH | Seychelles | $39.932 | $40.000 | Budget |
| 18 | HEALTH CITY CAYMAN I… | Cayman Islands | $38.676 | $10.000 | Budget |
| 19 | QUEEENS ENTERPRISES … | Sudan | $29.947 | $30.000 | Budget |
| 20 | MUBARAK HASHIMI LTD | Afghanistan | $29.618 | $30.000 | Budget |
| 21 | WOODLAND HOSPITAL | South Africa | $17.075 | $4.000 | Budget |
| 22 | REPUBLIC OF NAURU, D… | Australia | $11.156 | $6.000 | Budget |
| 23 | REPUBLIC OF NAURU - … | Nauru | $10.199 | $10.000 | Budget |
| 24 | TO THE PURCHASE DEPA… | Saint Vincent and the Grenadines | $8.522 | $9.000 | Budget |
| 25 | FOR THE ORDER OF | Yemen | $6.100 | $6.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 ACME GENERICS PVT LTD → JAMP PHARMA CORP is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian digoxin prices vary by supplier, country and dosage form
KEY TAKEAWAY
Digoxin prices span 10536× ($0.0006 → $6.00). The coefficient of variation is 1.62. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0006 | Lowest observed unit price |
| P5 | $0.0010 | 5th percentile |
| P25 | $0.064 | 25th percentile (Q1) |
| Median | $0.186 | 50th percentile (Q2) |
| P75 | $0.959 | 75th percentile (Q3) |
| P95 | $3.31 | 95th percentile |
| Max | $6.00 | Highest observed unit price |
| Mean | $0.767 | Arithmetic average |
| CV | 162% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 MYGENIC HEALTHCARE PVT LTD prices at $6.00/unit vs market median $0.186.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. S.D.PHARMACEUTICALS Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ACME GENERICS PVT Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | MYGENIC HEALTHCA… | Saudi Arabia | Injection | 230 | $1K | $6.00 | Sterile formulation premium |
| Nov 2025 | HOLDEN MEDICAL L… | Bhutan | Tablet | 637 | $3K | $4.98 | Specialty / small-batch |
| Nov 2025 | HOLDEN MEDICAL L… | Bhutan | Tablet | 2 | $9.95 | $4.98 | Specialty / small-batch |
| Dec 2025 | NIVIRA EXPORTS | Saint Vincent and the Grenadines | Injection | 2 | $8.52 | $4.26 | Sterile formulation premium |
| Oct 2025 | MANCARE PHARMACE… | Nigeria | Tablet | 2K | $5K | $2.90 | Specialty / small-batch |
| Dec 2025 | NARANG MEDICAL LTD | Mozambique | Solution | 2K | $5K | $2.83 | Specialty / small-batch |
| Dec 2025 | SAMARTH LIFE SCI… | Seychelles | Tablet | 150 | $393.88 | $2.63 | Specialty / small-batch |
| Dec 2025 | VELLINTON HEALTH… | Georgia | Injection | 10K | $26K | $2.61 | Sterile formulation premium |
| Dec 2025 | ACME GENERICS PV… | Canada | Tablet | 34K | $56K | $1.67 | Specialty / small-batch |
| Dec 2025 | ACME GENERICS PV… | Canada | Tablet | 6K | $10K | $1.67 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | AL-SUPREME EXPORTS | Seychelles | Tablet | 100 | $0.162 | $0.0016 | Bulk generic tablet |
| Dec 2025 | VEA IMPEX (I) PV… | Seychelles | Tablet | 35 | $0.059 | $0.0017 | Bulk generic tablet |
| Dec 2025 | NARAYANA HRUDAYA… | Cayman Islands | Injection | 10 | $0.023 | $0.0023 | Sterile formulation premium |
| Oct 2025 | CIRON DRUGS AND … | Guyana | Tablet | 500K | $4K | $0.0070 | Bulk generic tablet |
| Nov 2025 | S.D.PHARMACEUTIC… | Venezuela | Tablet | 31K | $219.80 | $0.0071 | Bulk generic tablet |
| Dec 2025 | GMSANJIVANI LLP | Somalia | Injection | 60 | $0.429 | $0.0071 | Sterile formulation premium |
| Dec 2025 | AZKA MEDTRADE AN… | Somalia | Tablet | 1K | $9.09 | $0.0091 | Bulk generic tablet |
| Oct 2025 | S.D.PHARMACEUTIC… | Venezuela | Tablet | 960K | $9K | $0.0092 | Bulk generic tablet |
| Dec 2025 | MEDMATRIX ASSOCI… | Afghanistan | Tablet | 500 | $4.92 | $0.0098 | Bulk generic tablet |
| Dec 2025 | AMPROMED PHARMA … | North Macedonia | Injection | 71 | $0.809 | $0.011 | Sterile formulation premium |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship digoxin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Digoxin leaves India through 16+ ports. The top 5 (DADRI ICD, AHMEDABAD ICD, NHAVA SHEVA SEA (JNPT)) handle 83.1% of total USD. ICD moves 21% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 DADRI ICD handles $56K — top 16 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 MONTREAL is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
ICD dominates at 21% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
ICD
$141K
72.6% of USD · 20.8% of ships
SEA
$29K
14.7% of USD · 18.2% of ships
AIR
$21K
11.0% of USD · 58.4% of ships
ROAD
$3K
1.6% of USD · 2.6% of ships
Fig 8.3 The dominant corridor is DADRI ICD → Sea → N. America ($56K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
South Africa is the most concentrated destination (HHI 10000, 1 suppliers). Venezuela is the most competitive (HHI 5012).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 South Africa (HHI 10,000) is the most concentrated — Venezuela (HHI 5,012) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| JAMP PHARMA CORP | Canada | ACME GENERICS PV… | $66K | 2 | MEDIUM |
| MINISTRY OF HEALTH A… | Georgia | VELLINTON HEALTH… | $26K | 1 | MEDIUM |
| BANK OF CEYLON | Sri Lanka | UNICURE REMEDIES… | $20K | 1 | MEDIUM |
| MANFES PHARMACEUTICA… | Nigeria | MANCARE PHARMACE… | $10K | 2 | MEDIUM |
| VISION DROMEFAR, C.A | Venezuela | S.D.PHARMACEUTIC… | $9K | 2 | MEDIUM |
| SAAD MEDICAL | Dominican Republic | MEDICO REMEDIES … | $5K | 1 | MEDIUM |
| KARMA PHARMACEUTICAL… | Bhutan | HOLDEN MEDICAL L… | $3K | 2 | MEDIUM |
| DERDE DERMAN | Turkmenistan | GOD GIFT LABORAT… | $2K | 3 | MEDIUM |
Conclusion: 31 buyers depend on exactly one Indian supplier, representing $146K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Canada | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Georgia | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Venezuela | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Mozambique | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Algeria | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Dominican Republic | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Guyana | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Bhutan | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Turkmenistan | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Zambia | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Saudi Arabia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Senegal | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 12 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Canada | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit South Africa lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Canada (1 suppliers) | This Q | HIGH |
| A6 | Enter Georgia (1 suppliers) | This Q | MED |
| A8 | Build Georgia distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Canada tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Canada | Other | 1 | $66K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Georgia | Other | 1 | $26K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Sri Lanka | Asia | 1 | $20K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Myanmar | Asia | 1 | $19K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Venezuela | Other | 2 | $17K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Mozambique | Africa | 2 | $8K | +22.8% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Nigeria | Africa | 1 | $10K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Algeria | Africa | 1 | $5K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Dominican Republic | Other | 1 | $5K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Turkmenistan | Asia | 1 | $2K | +93.1% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Guyana | Other | 3 | $4K | -91.9% | LOW | Low competition (3 suppliers), accessible market |
| 12 | Bhutan | Asia | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Zambia | Africa | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Saudi Arabia | Other | 3 | $2K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 15 | Senegal | Africa | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 77 2025-Q4 Digoxin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/digoxin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 77 2025-Q4 digoxin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian digoxin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
77
across all regions
TOTAL USD
$194K
2025-Q4 FOB value
UNITS
1.8M
tablets, capsules, etc.
SUPPLIERS
48
Indian exporters
BUYERS
33
global importers
COUNTRIES
38
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $28K (14.6%), spanning 15 countries.
48 Indian suppliers shipped to 33 buyers across 38 countries — average shipment value $3K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
15 countries · 32 shipments · $28K · 21 Indian suppliers · 14 buyers
SHIPMENTS
32
USD
$28K
COUNTRIES
15
SUPPLIERS
21
BUYERS
14
HHI
2,167
moderate
Top 15 destination countries in Africa
1
Nigeria (34.3%)
$10K
2
Mozambique (29.1%)
$8K
3
Algeria (18.2%)
$5K
4
Zambia (7.0%)
$2K
5
Senegal (4.2%)
$1K
6
Madagascar (1.9%)
$547.25
7
Angola (1.6%)
$445.01
8
Seychelles (1.5%)
$434.04
9
Somalia (1.2%)
$330.06
10
Guinea-Bissau (0.4%)
$118.55
11
Ghana (0.3%)
$88.70
12
Sudan (0.1%)
$33.15
13
South Africa (0.1%)
$17.07
14
Uganda (0.0%)
$0.228
15
Republic of the Congo (0.0%)
$0.090
Top 21 Indian suppliers into Africa
1
MANCARE PHARMACEUTICALS PVT LTD
$10K
2
SWISS PARENTERALS LTD
$6K
3
NARANG MEDICAL LTD
$5K
4
ALLOTAB HEALTHCARE LLP
$4K
5
PATSONS INTERNATIONAL
$2K
6
ACCRESHA LIFECARE PVT LTD
$547.25
7
AURA PHARMACEUTICALS PVT LTD
$445.01
8
SAMARTH LIFE SCIENCES PVT LTD
$393.88
9
WORLDPRIME EXPORT LLP
$317.44
10
TRIDENT IMPEX
$118.55
11
ZIRCON MEDTECH
$88.70
12
HLL LIFECARE LTD
$39.93
13
BAKER & DAVIS PVT LTD
$29.95
14
SUDDHASATTWA RAY
$17.07
15
AZKA MEDTRADE AND SERVICES
$12.19
16
AFRO LIFESCIENCE
$3.20
17
GMSANJIVANI LLP
$0.429
18
RUTVA MEDICARE
$0.228
19
AL-SUPREME EXPORTS
$0.162
20
PHARMAKWIK HEALTHTECH PVT LTD
$0.090
21
VEA IMPEX (I) PVT LTD
$0.059
Top 12 Africa importers
1
MANFES PHARMACEUTICALS CO. (NIG.) L · Nigeria
$10K
2
LUSAKA PHARMACEUTICALS LTD · Zambia
$2K
3
SALAMA(CENTRAL PURCHASING AGENCY · Madagascar
$547.25
4
TOTHE ORDER SHARJAH UNITED ARAB EMI · Angola
$445.01
5
SEYCHELLES HOSPITAL · Seychelles
$393.88
6
ALLIANCE PHARMA SARL · Guinea-Bissau
$118.55
7
MINISTRY OF HEALTH · Seychelles
$39.93
8
QUEEENS ENTERPRISES CO LTD · Sudan
$29.95
9
WOODLAND HOSPITAL · South Africa
$17.07
10
MADAU KUAAC AYAI KON · Sudan
$3.20
11
GOOD HEALTH (PTY) LTD · Seychelles
$0.162
12
TO: M/S SOCITETE CNVM · Republic of the Congo
$0.090
Top 4 dosage forms
1
Tablet
$13K
2
Injection
$11K
3
Solution
$5K
4
Unknown
$0.228
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 10 | $14K | $1K |
| Nov | 6 | $2K | $364.04 |
| Dec | 16 | $12K | $764.30 |
Shipment register · 32 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MANCARE PHARMACEUTICALS PVT LTD · 2 shipments · $10K | |||||||||||
| 1 | Oct 2025 | MANFES PHARMACEUTICALS CO. (NIG.) L | Nigeria | Tablet | 2.7K | NOS | $1.63 | $4K | NHAVA SHEVA SEA (JNPT) | Apapa | SEA |
| 2 | Oct 2025 | MANFES PHARMACEUTICALS CO. (NIG.) L | Nigeria | Tablet | 1.8K | NOS | $2.90 | $5K | NHAVA SHEVA SEA (JNPT) | Apapa | SEA |
| SUPPLIER #2 — SWISS PARENTERALS LTD · 2 shipments · $6K | |||||||||||
| 3 | Dec 2025 | UNLISTED BUYER | Algeria | Injection | 4.2K | NOS | $1.22 | $5K | AHMEDABAD AIR | ALGIERS | AIR |
| 4 | Dec 2025 | UNLISTED BUYER | Senegal | Injection | 7.5K | NOS | $0.160 | $1K | AHMEDABAD AIR | DAKAR | AIR |
| SUPPLIER #3 — NARANG MEDICAL LTD · 1 shipments · $5K | |||||||||||
| 5 | Dec 2025 | UNLISTED BUYER | Mozambique | Solution | 1.6K | PCS | $2.83 | $5K | TUGHLAKABAD ICD | Maputo | ICD |
| SUPPLIER #4 — ALLOTAB HEALTHCARE LLP · 4 shipments · $4K | |||||||||||
| 6 | Oct 2025 | UNKNOWN BUYER | Mozambique | Injection | 17.4K | PCS | $0.079 | $1K | TUGHLAKABAD ICD | Maputo | ICD |
| 7 | Oct 2025 | UNKNOWN BUYER | Mozambique | Injection | 5.8K | PCS | $0.079 | $457.39 | TUGHLAKABAD ICD | Maputo | ICD |
| 8 | Oct 2025 | UNKNOWN BUYER | Mozambique | Injection | 17.4K | PCS | $0.079 | $1K | TUGHLAKABAD ICD | Maputo | ICD |
| 9 | Oct 2025 | UNKNOWN BUYER | Mozambique | Injection | 5.8K | PCS | $0.079 | $457.39 | TUGHLAKABAD ICD | Maputo | ICD |
| SUPPLIER #5 — PATSONS INTERNATIONAL · 1 shipments · $2K | |||||||||||
| 10 | Nov 2025 | LUSAKA PHARMACEUTICALS LTD | Zambia | Tablet | 20.0K | NOS | $0.099 | $2K | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #6 — ACCRESHA LIFECARE PVT LTD · 1 shipments · $547.25 | |||||||||||
| 11 | Dec 2025 | SALAMA(CENTRAL PURCHASING AGENCY | Madagascar | Tablet | 500 | NOS | $1.09 | $547.25 | AHMEDABAD ICD | TOAMASINA | ICD |
| SUPPLIER #7 — AURA PHARMACEUTICALS PVT LTD · 2 shipments · $445.01 | |||||||||||
| 12 | Oct 2025 | TOTHE ORDER SHARJAH UNITED ARAB EMI | Angola | Injection | 200 | NOS | $1.11 | $222.50 | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| 13 | Oct 2025 | TOTHE ORDER SHARJAH UNITED ARAB EMI | Angola | Injection | 200 | NOS | $1.11 | $222.50 | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| SUPPLIER #8 — SAMARTH LIFE SCIENCES PVT LTD · 1 shipments · $393.88 | |||||||||||
| 14 | Dec 2025 | SEYCHELLES HOSPITAL | Seychelles | Tablet | 150 | NOS | $2.63 | $393.88 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| SUPPLIER #9 — WORLDPRIME EXPORT LLP · 1 shipments · $317.44 | |||||||||||
| 15 | Dec 2025 | UNLISTED BUYER | Somalia | Tablet | 500 | NOS | $0.635 | $317.44 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #10 — TRIDENT IMPEX · 1 shipments · $118.55 | |||||||||||
| 16 | Nov 2025 | ALLIANCE PHARMA SARL | Guinea-Bissau | Tablet | 100 | NOS | $1.19 | $118.55 | NHAVA SHEVA SEA (JNPT) | Dakar | SEA |
| SUPPLIER #11 — ZIRCON MEDTECH · 1 shipments · $88.70 | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Ghana | Injection | 1.0K | NOS | $0.089 | $88.70 | AHMEDABAD AIR | ACCRA | AIR |
| SUPPLIER #12 — HLL LIFECARE LTD · 1 shipments · $39.93 | |||||||||||
| 18 | Nov 2025 | MINISTRY OF HEALTH | Seychelles | Tablet | 40.0K | NOS | $0.0010 | $39.93 | DELHI AIR | MAHE ISLAND | AIR |
| SUPPLIER #13 — BAKER & DAVIS PVT LTD · 1 shipments · $29.95 | |||||||||||
| 19 | Nov 2025 | QUEEENS ENTERPRISES CO LTD | Sudan | Tablet | 500 | NOS | $0.060 | $29.95 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| SUPPLIER #14 — SUDDHASATTWA RAY · 4 shipments · $17.07 | |||||||||||
| 20 | Oct 2025 | WOODLAND HOSPITAL | South Africa | Injection | 5 | PCS | $0.854 | $4.27 | KOLKATA AIR CARGO | GEORGETOWN | AIR |
| 21 | Oct 2025 | WOODLAND HOSPITAL | South Africa | Injection | 5 | PCS | $0.854 | $4.27 | KOLKATA AIR CARGO | GEORGETOWN | AIR |
| 22 | Nov 2025 | WOODLAND HOSPITAL | South Africa | Injection | 5 | PCS | $0.853 | $4.27 | KOLKATA AIR | GEORGETOWN | AIR |
| 23 | Nov 2025 | WOODLAND HOSPITAL | South Africa | Injection | 5 | PCS | $0.853 | $4.27 | KOLKATA AIR | GEORGETOWN | AIR |
| SUPPLIER #15 — AZKA MEDTRADE AND SERVICES · 3 shipments · $12.19 | |||||||||||
| 24 | Dec 2025 | UNLISTED BUYER | Somalia | Tablet | 1.0K | NOS | $0.0091 | $9.09 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 25 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 2.1K | NOS | $0.0008 | $1.65 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 26 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 1.9K | NOS | $0.0008 | $1.45 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #16 — AFRO LIFESCIENCE · 1 shipments · $3.20 | |||||||||||
| 27 | Dec 2025 | MADAU KUAAC AYAI KON | Sudan | Tablet | 100 | PCS | $0.032 | $3.20 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| SUPPLIER #17 — GMSANJIVANI LLP · 1 shipments · $0.429 | |||||||||||
| 28 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 60 | NOS | $0.0071 | $0.429 | NHAVA SHEVA SEA (JNPT) | Mogadishu | SEA |
| SUPPLIER #18 — RUTVA MEDICARE · 1 shipments · $0.228 | |||||||||||
| 29 | Dec 2025 | UNLISTED BUYER | Uganda | 400 | NOS | $0.0006 | $0.228 | MUMBAI AIR (SAHAR) | ENTEBBE | AIR | |
| SUPPLIER #19 — AL-SUPREME EXPORTS · 1 shipments · $0.162 | |||||||||||
| 30 | Dec 2025 | GOOD HEALTH (PTY) LTD | Seychelles | Tablet | 100 | NOS | $0.0016 | $0.162 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #20 — PHARMAKWIK HEALTHTECH PVT LTD · 1 shipments · $0.090 | |||||||||||
| 31 | Dec 2025 | TO: M/S SOCITETE CNVM | Republic of the Congo | Injection | 100 | NOS | $0.0009 | $0.090 | MUMBAI AIR (SAHAR) | BRAZZAVILLE | AIR |
| SUPPLIER #21 — VEA IMPEX (I) PVT LTD · 1 shipments · $0.059 | |||||||||||
| 32 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 35 | NOS | $0.0017 | $0.059 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
11 countries · 21 shipments · $73K · 14 Indian suppliers · 11 buyers
SHIPMENTS
21
USD
$73K
COUNTRIES
11
SUPPLIERS
14
BUYERS
11
HHI
2,778
concentrated
Top 11 destination countries in Asia
1
Georgia (35.8%)
$26K
2
Sri Lanka (27.7%)
$20K
3
Myanmar (26.3%)
$19K
4
Bhutan (4.4%)
$3K
5
Turkmenistan (3.4%)
$2K
6
Saudi Arabia (2.3%)
$2K
7
Afghanistan (0.0%)
$34.54
8
Oman (0.0%)
$15.31
9
Yemen (0.0%)
$6.10
10
United Arab Emirates (0.0%)
$3.96
11
Bangladesh · Bangladesh
$0.0000
Top 14 Indian suppliers into Asia
1
VELLINTON HEALTHCARE
$26K
2
UNICURE REMEDIES PVT LTD
$20K
3
SWIPHA EXPORTS PVT LTD
$19K
4
HOLDEN MEDICAL LABORATORIES PVT LTD
$3K
5
GOD GIFT LABORATORY PVT LTD
$2K
6
MYGENIC HEALTHCARE PVT LTD
$1K
7
SONIA LABORATORY PVT LTD
$220.44
8
GENEX PHARMA
$74.24
9
KERK
$29.62
10
VEA IMPEX (I) PVT LTD
$15.31
11
3S CORP
$6.10
12
MEDMATRIX ASSOCIATES
$4.92
13
DROPS PHARMA PVT LTD
$3.44
14
CLOVERLEAF ECOM PVT LTD
$0.520
Top 9 Asia importers
1
MINISTRY OF HEALTH AND MEDICAL INDU · Georgia
$26K
2
BANK OF CEYLON · Sri Lanka
$20K
3
KARMA PHARMACEUTICAL & MEDICAL SUPP · Bhutan
$3K
4
DERDE DERMAN · Turkmenistan
$2K
5
AL MAAYER ALASRYAH COMPANY · Saudi Arabia
$220.44
6
MUBARAK HASHIMI LTD · Afghanistan
$29.62
7
FOR THE ORDER OF · Yemen
$6.10
8
GULF IMPEX FZC · Afghanistan
$4.92
9
EMIRATES POST GROUP · United Arab Emirates
$0.520
Top 2 dosage forms
1
Tablet
$45K
2
Injection
$28K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $21K | $11K |
| Nov | 3 | $13K | $4K |
| Dec | 16 | $39K | $2K |
Shipment register · 21 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — VELLINTON HEALTHCARE · 1 shipments · $26K | |||||||||||
| 1 | Dec 2025 | MINISTRY OF HEALTH AND MEDICAL INDU | Georgia | Injection | 10.0K | NOS | $2.61 | $26K | LUDHIANA ICD | POTI | ICD |
| SUPPLIER #2 — UNICURE REMEDIES PVT LTD · 1 shipments · $20K | |||||||||||
| 2 | Oct 2025 | BANK OF CEYLON | Sri Lanka | Tablet | 16.0K | NOS | $1.26 | $20K | AHMEDABAD ICD | COLOMBO | ICD |
| SUPPLIER #3 — SWIPHA EXPORTS PVT LTD · 2 shipments · $19K | |||||||||||
| 3 | Nov 2025 | UNLISTED BUYER | Myanmar | Tablet | 10.0K | NOS | $0.948 | $9K | AHMEDABAD ICD | YANGON | ICD |
| 4 | Dec 2025 | UNLISTED BUYER | Myanmar | Tablet | 10.0K | NOS | $0.969 | $10K | AHMEDABAD ICD | YANGON | ICD |
| SUPPLIER #4 — HOLDEN MEDICAL LABORATORIES PVT LTD · 2 shipments · $3K | |||||||||||
| 5 | Nov 2025 | KARMA PHARMACEUTICAL & MEDICAL SUPP | Bhutan | Tablet | 2 | NOS | $4.98 | $9.95 | JAIGAON LCS | Phuntsholing | ROAD |
| 6 | Nov 2025 | KARMA PHARMACEUTICAL & MEDICAL SUPP | Bhutan | Tablet | 637 | NOS | $4.98 | $3K | JAIGAON LCS | Phuntsholing | ROAD |
| SUPPLIER #5 — GOD GIFT LABORATORY PVT LTD · 3 shipments · $2K | |||||||||||
| 7 | Oct 2025 | DERDE DERMAN | Turkmenistan | Tablet | 2.5K | TBS | $0.341 | $845.12 | DADRI - STTPL (CFS) | ASHKHABAD | ICD |
| 8 | Dec 2025 | DERDE DERMAN | Turkmenistan | Tablet | 2.4K | NOS | $0.340 | $816.00 | NHAVA SHEVA SEA (JNPT) | Ashkhabad | SEA |
| 9 | Dec 2025 | DERDE DERMAN | Turkmenistan | Tablet | 2.4K | NOS | $0.340 | $816.00 | NHAVA SHEVA SEA (JNPT) | Ashkhabad | SEA |
| SUPPLIER #6 — MYGENIC HEALTHCARE PVT LTD · 1 shipments · $1K | |||||||||||
| 10 | Dec 2025 | UNKNOWN BUYER | Saudi Arabia | Injection | 230 | NOS | $6.00 | $1K | MUMBAI AIR (SAHAR) | JEDDAH | AIR |
| SUPPLIER #7 — SONIA LABORATORY PVT LTD · 1 shipments · $220.44 | |||||||||||
| 11 | Dec 2025 | AL MAAYER ALASRYAH COMPANY | Saudi Arabia | Injection | 1.5K | NOS | $0.147 | $220.44 | MUMBAI AIR (SAHAR) | JEDDAH | AIR |
| SUPPLIER #8 — GENEX PHARMA · 2 shipments · $74.24 | |||||||||||
| 12 | Dec 2025 | UNLISTED BUYER | Bangladesh | Injection | 100 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DHAKA | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Injection | 100 | NOS | $0.742 | $74.24 | MUMBAI AIR (SAHAR) | JEDDAH | AIR |
| SUPPLIER #9 — KERK · 1 shipments · $29.62 | |||||||||||
| 14 | Dec 2025 | MUBARAK HASHIMI LTD | Afghanistan | Tablet | 240 | NOS | $0.123 | $29.62 | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #10 — VEA IMPEX (I) PVT LTD · 3 shipments · $15.31 | |||||||||||
| 15 | Dec 2025 | UNLISTED BUYER | Oman | Injection | 60 | NOS | $0.102 | $6.12 | MUMBAI AIR (SAHAR) | MUSCAT | AIR |
| 16 | Dec 2025 | UNLISTED BUYER | Oman | Injection | 60 | NOS | $0.102 | $6.12 | MUMBAI AIR (SAHAR) | MUSCAT | AIR |
| 17 | Dec 2025 | UNLISTED BUYER | Oman | Injection | 30 | NOS | $0.102 | $3.06 | MUMBAI AIR (SAHAR) | MUSCAT | AIR |
| SUPPLIER #11 — 3S CORP · 1 shipments · $6.10 | |||||||||||
| 18 | Dec 2025 | FOR THE ORDER OF | Yemen | Tablet | 50 | NOS | $0.122 | $6.10 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #12 — MEDMATRIX ASSOCIATES · 1 shipments · $4.92 | |||||||||||
| 19 | Dec 2025 | GULF IMPEX FZC | Afghanistan | Tablet | 500 | NOS | $0.0098 | $4.92 | DADRI ICD | KABUL | ICD |
| SUPPLIER #13 — DROPS PHARMA PVT LTD · 1 shipments · $3.44 | |||||||||||
| 20 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 4 | NOS | $0.859 | $3.44 | COCHIN AIR | DUBAI | AIR |
| SUPPLIER #14 — CLOVERLEAF ECOM PVT LTD · 1 shipments · $0.520 | |||||||||||
| 21 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 3 | NOS | $0.173 | $0.520 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
2 countries · 3 shipments · $4.62 · 2 Indian suppliers · 2 buyers
SHIPMENTS
3
USD
$4.62
COUNTRIES
2
SUPPLIERS
2
BUYERS
2
HHI
7,111
concentrated
Top 2 destination countries in Europe
1
Netherlands (82.5%)
$3.81
2
North Macedonia (17.5%)
$0.809
Top 2 Indian suppliers into Europe
1
RUCHA ENTERPRISES
$3.81
2
AMPROMED PHARMA INTERNATIONAL
$0.809
Top 1 Europe importers
1
INVOICE RAISED TO · North Macedonia
$0.809
Top 2 dosage forms
1
Injection
$3.31
2
Tablet
$1.31
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 3 | $4.62 | $1.54 |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RUCHA ENTERPRISES · 2 shipments · $3.81 | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Netherlands | Injection | 10 | NOS | $0.250 | $2.50 | MUMBAI AIR (SAHAR) | AMSTERDAM, SCHIPHOL | AIR |
| 2 | Dec 2025 | UNLISTED BUYER | Netherlands | Tablet | 4 | NOS | $0.327 | $1.31 | MUMBAI AIR (SAHAR) | AMSTERDAM, SCHIPHOL | AIR |
| SUPPLIER #2 — AMPROMED PHARMA INTERNATIONAL · 1 shipments · $0.809 | |||||||||||
| 3 | Dec 2025 | INVOICE RAISED TO | North Macedonia | Injection | 71 | NOS | $0.011 | $0.809 | MUMBAI AIR (SAHAR) | SKOPJE | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
7 countries · 17 shipments · $93K · 10 Indian suppliers · 7 buyers
SHIPMENTS
17
USD
$93K
COUNTRIES
7
SUPPLIERS
10
BUYERS
7
HHI
5,372
concentrated
Top 7 destination countries in Americas
1
Canada (71.8%)
$66K
2
Venezuela (18.7%)
$17K
3
Dominican Republic (5.3%)
$5K
4
Guyana (4.1%)
$4K
5
Cayman Islands (0.0%)
$38.68
6
Saint Vincent and the Grenadines (0.0%)
$8.52
7
Saint Kitts and Nevis (0.0%)
$0.258
Top 10 Indian suppliers into Americas
1
ACME GENERICS PVT LTD
$66K
2
S.D.PHARMACEUTICALS
$9K
3
RONALD PHARMACEUTICALS PVT LTD
$8K
4
MEDICO REMEDIES LTD
$5K
5
CIRON DRUGS AND PHARMACEUTICALS PVT LTD
$4K
6
H V A INTERNATIONAL
$279.46
7
NARAYANA HRUDAYALAYA LTD
$38.68
8
NIVIRA EXPORTS
$8.52
9
PEAK HEALTHCARE
$5.51
10
FINDLIFE PHARMACEUTICAL
$0.258
Top 6 Americas importers
1
JAMP PHARMA CORP · Canada
$66K
2
VISION DROMEFAR, C.A · Venezuela
$9K
3
SAAD MEDICAL · Dominican Republic
$5K
4
NEW GPC INC · Guyana
$279.46
5
HEALTH CITY CAYMAN ISLANDS (HCCI) · Cayman Islands
$38.68
6
TO THE PURCHASE DEPARTMENT · Saint Vincent and the Grenadines
$8.52
Top 4 dosage forms
1
Tablet
$92K
2
Syrup
$279.46
3
Injection
$18.02
4
Solution
$0.258
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $21K | $5K |
| Nov | 1 | $219.80 | $219.80 |
| Dec | 12 | $72K | $6K |
Shipment register · 17 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ACME GENERICS PVT LTD · 2 shipments · $66K | |||||||||||
| 1 | Dec 2025 | JAMP PHARMA CORP | Canada | Tablet | 6.0K | NOS | $1.67 | $10K | DELHI AIR | MONTREAL, QC | AIR |
| 2 | Dec 2025 | JAMP PHARMA CORP | Canada | Tablet | 33.9K | NOS | $1.67 | $56K | DADRI ICD | MONTREAL | ICD |
| SUPPLIER #2 — S.D.PHARMACEUTICALS · 2 shipments · $9K | |||||||||||
| 3 | Oct 2025 | VISION DROMEFAR, C.A | Venezuela | Tablet | 960.0K | NOS | $0.0092 | $9K | CHAWAPAYAL ICD | LA GUAIRA | ICD |
| 4 | Nov 2025 | VISION DROMEFAR, C.A | Venezuela | Tablet | 30.9K | NOS | $0.0071 | $219.80 | CHAWAPAYAL ICD | LA GUAIRA | ICD |
| SUPPLIER #3 — RONALD PHARMACEUTICALS PVT LTD · 1 shipments · $8K | |||||||||||
| 5 | Oct 2025 | UNLISTED BUYER | Venezuela | Tablet | 16.5K | NOS | $0.501 | $8K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| SUPPLIER #4 — MEDICO REMEDIES LTD · 1 shipments · $5K | |||||||||||
| 6 | Dec 2025 | SAAD MEDICAL | Dominican Republic | Tablet | 12.0K | NOS | $0.411 | $5K | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| SUPPLIER #5 — CIRON DRUGS AND PHARMACEUTICALS PVT LTD · 1 shipments · $4K | |||||||||||
| 7 | Oct 2025 | UNLISTED BUYER | Guyana | Tablet | 500.0K | NOS | $0.0070 | $4K | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #6 — H V A INTERNATIONAL · 1 shipments · $279.46 | |||||||||||
| 8 | Dec 2025 | NEW GPC INC | Guyana | Syrup | 200 | NOS | $1.40 | $279.46 | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| SUPPLIER #7 — NARAYANA HRUDAYALAYA LTD · 4 shipments · $38.68 | |||||||||||
| 9 | Oct 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Injection | 20 | NOS | $0.198 | $3.96 | BANGALORE AIR | GEORGETOWN | AIR |
| 10 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Tablet | 200 | NOS | $0.102 | $20.41 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| 11 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Injection | 10 | NOS | $0.0023 | $0.023 | BANGALORE AIR | GEORGETOWN | AIR |
| 12 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Tablet | 70 | NOS | $0.204 | $14.28 | BANGALORE AIR | GEORGETOWN | AIR |
| SUPPLIER #8 — NIVIRA EXPORTS · 1 shipments · $8.52 | |||||||||||
| 13 | Dec 2025 | TO THE PURCHASE DEPARTMENT | Saint Vincent and the Grenadines | Injection | 2 | NOS | $4.26 | $8.52 | MUMBAI AIR (SAHAR) | KETCHIKAN, AK | AIR |
| SUPPLIER #9 — PEAK HEALTHCARE · 3 shipments · $5.51 | |||||||||||
| 14 | Dec 2025 | UNLISTED BUYER | Guyana | Injection | 40 | NOS | $0.069 | $2.76 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 15 | Dec 2025 | UNLISTED BUYER | Guyana | Injection | 40 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 16 | Dec 2025 | UNLISTED BUYER | Guyana | Injection | 40 | NOS | $0.069 | $2.75 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #10 — FINDLIFE PHARMACEUTICAL · 1 shipments · $0.258 | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Saint Kitts and Nevis | Solution | 12 | NOS | $0.021 | $0.258 | DELHI AIR | ST KITTS | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
3 countries · 4 shipments · $102.04 · 3 Indian suppliers · 3 buyers
SHIPMENTS
4
USD
$102.04
COUNTRIES
3
SUPPLIERS
3
BUYERS
3
HHI
6,472
concentrated
Top 3 destination countries in Oceania
1
Fiji (79.1%)
$80.69
2
Australia (10.9%)
$11.16
3
Nauru (10.0%)
$10.20
Top 3 Indian suppliers into Oceania
1
MODERN DRUG HOUSE
$80.69
2
SYNERGY TRADING
$11.16
3
HLL LIFECARE LTD
$10.20
Top 3 Oceania importers
1
TO,THE ORDER OF · Fiji
$80.69
2
REPUBLIC OF NAURU, DEPARTMENT OF · Australia
$11.16
3
REPUBLIC OF NAURU - DEPARTMENT OF H · Nauru
$10.20
Top 2 dosage forms
1
Injection
$91.84
2
Tablet
$10.20
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 2 | $11.16 | $5.58 |
| Dec | 2 | $90.89 | $45.44 |
Shipment register · 4 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MODERN DRUG HOUSE · 1 shipments · $80.69 | |||||||||||
| 1 | Dec 2025 | TO,THE ORDER OF | Fiji | Injection | 500 | NOS | $0.161 | $80.69 | MUMBAI AIR (SAHAR) | NADI | AIR |
| SUPPLIER #2 — SYNERGY TRADING · 2 shipments · $11.16 | |||||||||||
| 2 | Nov 2025 | REPUBLIC OF NAURU, DEPARTMENT OF | Australia | Injection | 30 | NOS | $0.186 | $5.58 | MUMBAI AIR (SAHAR) | BRISBANE | AIR |
| 3 | Nov 2025 | REPUBLIC OF NAURU, DEPARTMENT OF | Australia | Injection | 30 | NOS | $0.186 | $5.58 | MUMBAI AIR (SAHAR) | BRISBANE | AIR |
| SUPPLIER #3 — HLL LIFECARE LTD · 1 shipments · $10.20 | |||||||||||
| 4 | Dec 2025 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | Tablet | 500 | NOS | $0.020 | $10.20 | DELHI AIR | NAURU ISLAND | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 48 Indian digoxin exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped digoxin in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | ACME GENERICS PVT LTD | NALAGARH | 2 | $66K | Tablet | Americas |
| 2 | VELLINTON HEALTHCARE | KALA AMB TEHSIL NAHAN | 1 | $26K | Injection | Asia |
| 3 | UNICURE REMEDIES PVT LTD | VADODARA | 1 | $20K | Tablet | Asia |
| 4 | SWIPHA EXPORTS PVT LTD | AHMEDABAD | 2 | $19K | Tablet | Asia |
| 5 | MANCARE PHARMACEUTICALS PVT LTD | VASAI ROAD (W) | 2 | $10K | Tablet | Africa |
| 6 | S.D.PHARMACEUTICALS | CENTER VIKAS PURI NEW DELHI | 2 | $9K | Tablet | Americas |
| 7 | RONALD PHARMACEUTICALS PVT LTD | VADODARA | 1 | $8K | Tablet | Americas |
| 8 | SWISS PARENTERALS LTD | AHMEDABAD | 2 | $6K | Injection | Africa |
| 9 | MEDICO REMEDIES LTD | PALGHAR WEST | 1 | $5K | Tablet | Americas |
| 10 | NARANG MEDICAL LTD | NEW DELHI | 1 | $5K | Solution | Africa |
| 11 | ALLOTAB HEALTHCARE LLP | Ahmedabad | 4 | $4K | Injection | Africa |
| 12 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD | MUMBAI | 1 | $4K | Tablet | Americas |
| 13 | HOLDEN MEDICAL LABORATORIES PVT LTD | NASHIK | 2 | $3K | Tablet | Asia |
| 14 | GOD GIFT LABORATORY PVT LTD | SONEPAT | 3 | $2K | Tablet | Asia |
| 15 | PATSONS INTERNATIONAL | ANAND | 1 | $2K | Tablet | Africa |
| 16 | MYGENIC HEALTHCARE PVT LTD | NAVI MUMBAI | 1 | $1K | Injection | Asia |
| 17 | ACCRESHA LIFECARE PVT LTD | AHMEDABAD | 1 | $547.25 | Tablet | Africa |
| 18 | AURA PHARMACEUTICALS PVT LTD | MUMBAI M S | 2 | $445.01 | Injection | Africa |
| 19 | SAMARTH LIFE SCIENCES PVT LTD | Punjab | 1 | $393.88 | Tablet | Africa |
| 20 | WORLDPRIME EXPORT LLP | JUNAGADH | 1 | $317.44 | Tablet | Africa |
| 21 | H V A INTERNATIONAL | VILE PARLE EAST | 1 | $279.46 | Syrup | Americas |
| 22 | SONIA LABORATORY PVT LTD | VADODARA | 1 | $220.44 | Injection | Asia |
| 23 | TRIDENT IMPEX | MUMBAI | 1 | $118.55 | Tablet | Africa |
| 24 | ZIRCON MEDTECH | VADODARA | 1 | $88.70 | Injection | Africa |
| 25 | MODERN DRUG HOUSE | MUMBAI | 1 | $80.69 | Injection | Oceania |
| 26 | GENEX PHARMA | MUMBAI MAHARASHTRA | 2 | $74.24 | Injection | Asia |
| 27 | HLL LIFECARE LTD | UTTAR PRADESH | 2 | $50.13 | Tablet | Africa, Oceania |
| 28 | NARAYANA HRUDAYALAYA LTD | BANGALORE | 4 | $38.68 | Injection, Tablet | Americas |
| 29 | BAKER & DAVIS PVT LTD | MUMBAI | 1 | $29.95 | Tablet | Africa |
| 30 | KERK | DELHI | 1 | $29.62 | Tablet | Asia |
| 31 | SUDDHASATTWA RAY | BHOWANIPORE KOLKATA | 4 | $17.07 | Injection | Africa |
| 32 | VEA IMPEX (I) PVT LTD | MUMBAI | 4 | $15.36 | Injection, Tablet | Asia, Africa |
| 33 | AZKA MEDTRADE AND SERVICES | MUMBAI | 3 | $12.19 | Tablet, Injection | Africa |
| 34 | SYNERGY TRADING | VADODARA/GUJARAT | 2 | $11.16 | Injection | Oceania |
| 35 | NIVIRA EXPORTS | MUMBAI | 1 | $8.52 | Injection | Americas |
| 36 | 3S CORP | MUMBAI | 1 | $6.10 | Tablet | Asia |
| 37 | PEAK HEALTHCARE | MUMBAI | 3 | $5.51 | Injection | Americas |
| 38 | MEDMATRIX ASSOCIATES | AMBALA | 1 | $4.92 | Tablet | Asia |
| 39 | RUCHA ENTERPRISES | MUMBAI | 2 | $3.81 | Injection, Tablet | Europe |
| 40 | DROPS PHARMA PVT LTD | HOSDURG | 1 | $3.44 | Injection | Asia |
| 41 | AFRO LIFESCIENCE | MUMBAI | 1 | $3.20 | Tablet | Africa |
| 42 | AMPROMED PHARMA INTERNATIONAL | Dombivli | 1 | $0.809 | Injection | Europe |
| 43 | CLOVERLEAF ECOM PVT LTD | NAGPUR | 1 | $0.520 | Tablet | Asia |
| 44 | GMSANJIVANI LLP | MUMBAI | 1 | $0.429 | Injection | Africa |
| 45 | FINDLIFE PHARMACEUTICAL | SURAT | 1 | $0.258 | Solution | Americas |
| 46 | RUTVA MEDICARE | SURAT | 1 | $0.228 | Africa | |
| 47 | AL-SUPREME EXPORTS | NAGERCOIL | 1 | $0.162 | Tablet | Africa |
| 48 | PHARMAKWIK HEALTHTECH PVT LTD | Mumbai | 1 | $0.090 | Injection | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 31 global digoxin importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian digoxin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | JAMP PHARMA CORP | Canada | 2 | $66K | ACME GENERICS PVT LTD | Tablet |
| 2 | MINISTRY OF HEALTH AND MEDICAL INDU | Georgia | 1 | $26K | VELLINTON HEALTHCARE | Injection |
| 3 | BANK OF CEYLON | Sri Lanka | 1 | $20K | UNICURE REMEDIES PVT… | Tablet |
| 4 | MANFES PHARMACEUTICALS CO. (NIG.) L | Nigeria | 2 | $10K | MANCARE PHARMACEUTIC… | Tablet |
| 5 | VISION DROMEFAR, C.A | Venezuela | 2 | $9K | S.D.PHARMACEUTICALS | Tablet |
| 6 | SAAD MEDICAL | Dominican Republic | 1 | $5K | MEDICO REMEDIES LTD | Tablet |
| 7 | KARMA PHARMACEUTICAL & MEDICAL SUPP | Bhutan | 2 | $3K | HOLDEN MEDICAL LABOR… | Tablet |
| 8 | DERDE DERMAN | Turkmenistan | 3 | $2K | GOD GIFT LABORATORY … | Tablet |
| 9 | LUSAKA PHARMACEUTICALS LTD | Zambia | 1 | $2K | PATSONS INTERNATIONAL | Tablet |
| 10 | SALAMA(CENTRAL PURCHASING AGENCY | Madagascar | 1 | $547.25 | ACCRESHA LIFECARE PV… | Tablet |
| 11 | TOTHE ORDER SHARJAH UNITED ARAB EMI | Angola | 2 | $445.01 | AURA PHARMACEUTICALS… | Injection |
| 12 | SEYCHELLES HOSPITAL | Seychelles | 1 | $393.88 | SAMARTH LIFE SCIENCE… | Tablet |
| 13 | NEW GPC INC | Guyana | 1 | $279.46 | H V A INTERNATIONAL | Syrup |
| 14 | AL MAAYER ALASRYAH COMPANY | Saudi Arabia | 1 | $220.44 | SONIA LABORATORY PVT… | Injection |
| 15 | ALLIANCE PHARMA SARL | Guinea-Bissau | 1 | $118.55 | TRIDENT IMPEX | Tablet |
| 16 | TO,THE ORDER OF | Fiji | 1 | $80.69 | MODERN DRUG HOUSE | Injection |
| 17 | MINISTRY OF HEALTH | Seychelles | 1 | $39.93 | HLL LIFECARE LTD | Tablet |
| 18 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | 4 | $38.68 | NARAYANA HRUDAYALAYA… | Injection, Tablet |
| 19 | QUEEENS ENTERPRISES CO LTD | Sudan | 1 | $29.95 | BAKER & DAVIS PVT LTD | Tablet |
| 20 | MUBARAK HASHIMI LTD | Afghanistan | 1 | $29.62 | KERK | Tablet |
| 21 | WOODLAND HOSPITAL | South Africa | 4 | $17.07 | SUDDHASATTWA RAY | Injection |
| 22 | REPUBLIC OF NAURU, DEPARTMENT OF | Australia | 2 | $11.16 | SYNERGY TRADING | Injection |
| 23 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | 1 | $10.20 | HLL LIFECARE LTD | Tablet |
| 24 | TO THE PURCHASE DEPARTMENT | Saint Vincent and the Grenadines | 1 | $8.52 | NIVIRA EXPORTS | Injection |
| 25 | FOR THE ORDER OF | Yemen | 1 | $6.10 | 3S CORP | Tablet |
| 26 | GULF IMPEX FZC | Afghanistan | 1 | $4.92 | MEDMATRIX ASSOCIATES | Tablet |
| 27 | MADAU KUAAC AYAI KON | Sudan | 1 | $3.20 | AFRO LIFESCIENCE | Tablet |
| 28 | INVOICE RAISED TO | North Macedonia | 1 | $0.809 | AMPROMED PHARMA INTE… | Injection |
| 29 | EMIRATES POST GROUP | United Arab Emirates | 1 | $0.520 | CLOVERLEAF ECOM PVT … | Tablet |
| 30 | GOOD HEALTH (PTY) LTD | Seychelles | 1 | $0.162 | AL-SUPREME EXPORTS | Tablet |
| 31 | TO: M/S SOCITETE CNVM | Republic of the Congo | 1 | $0.090 | PHARMAKWIK HEALTHTEC… | Injection |
This report covers 77 2025-Q4 Digoxin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/digoxin
Talk to our trade analyst
Need a custom digoxin report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/digoxin
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Digoxin product page
Live data, supplier directory, price trends, and trade route analysis